Our data indicate that high GAPDH as well as low BEC-index based on mRNA are associated with early disease progression in patients with advanced high-grade serous adenocarcinomas of the ovary, fallopian tube or peritoneum. Here, GAPDH is linked to serous adenocarcinoma.